US · Healthcare

Tharimmune Inc. (THAR)

Biotechnology

Tharimmune Inc. (THAR) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for THAR

P/E ratio

25.00

Tharimmune Inc. (THAR) — FAQ

What is THAR's P/E ratio?

The price-to-earnings (P/E) ratio for Tharimmune Inc. (THAR) is 25.00 (data as of 2026-05-24).

Does Tharimmune Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Tharimmune Inc. (THAR). Check the MyAverix Finance app for the latest dividend data.

What sector is Tharimmune Inc. in?

Tharimmune Inc. (THAR) is classified in the Healthcare sector (Biotechnology industry).

What exchange is THAR listed on?

THAR is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)